MAGNESIUM OXIDE- magnesium oxide tablet 
APNAR PHARMA LP

----------

Magnesium Oxide 400 mg Tablets

Active Ingredients (in each tablet)

Magnesium Oxide 400 mg (241.3 mg elemental magnesium)

Purpose

Antacid

Uses

relieves

Warnings

Ask a doctor before use if you have kidney disease

Ask a doctor or pharmacist before use if you are taking a prescription drug. Antacid may interact with certain prescription drugs.

Do not take more than 2 tablets in a 24 hour period or use the maximum dosage of this product for more than two weeks, except under the advice and supervision of a physician

If pregnant or breast-feeding, ask a professional before use

Keep out of reach of children

Directions

Antacid Directions: take 1 tablet twice a day or as directed by a physician

Magnesium Supplement Directions: take 1 or 2 tablets day or as directed by a physician

Other information

Inactive Ingredients

Colloidal silicon dioxide, croscarmellose sodium, microcrystalline cellulose, stearic acid, maize starch

Questions or comments?

1-855-642-2594

Rev.: 04/2022

Manufactured by:

APNAR PHARMA LLP

East Windsor, NJ 08520

Made in USA

NDC 24689-132-01

Magnesium Oxide Tablets 400 mg

241.3 mg elemental Magnesium per tablet

Dietary supplement, Antacid

120 Tablets

Magnesium Oxide 400mg Tablets label

MAGNESIUM OXIDE 
magnesium oxide tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:24689-132
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM OXIDE400 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
STARCH, CORN (UNII: O8232NY3SJ)  
Product Characteristics
Colorwhite (White to off white) Score2 pieces
ShapeROUND (Round shaped standard concave) Size11mm
FlavorImprint Code AM3
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:24689-132-01120 in 1 BOTTLE; Type 0: Not a Combination Product08/05/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00108/05/2022
Labeler - APNAR PHARMA LP (079568229)
Establishment
NameAddressID/FEIBusiness Operations
INVAHEALTH INC116840615pack(24689-132) , label(24689-132)
Establishment
NameAddressID/FEIBusiness Operations
APNAR PHARMA LLP118530917manufacture(24689-132) , analysis(24689-132) , pack(24689-132)

Revised: 10/2023
Document Id: 08353d99-4377-eb64-e063-6294a90aa949
Set id: e4ef2224-07e4-e913-e053-2995a90a28ed
Version: 2
Effective Time: 20231021
 
APNAR PHARMA LP